Fig. 1From: Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristicsFlow chart showing distribution of study subjects and medications used for KD. The numbers in parentheses denote the overall number of patients. KD: Kawasaki disease, IVIG: IntraVenous ImmunoGlobulin, IFX: Infliximab, CyA: cyclosporin, mPSL: methylprednisoloneBack to article page